BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 31407032)

  • 41. The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes.
    Pereira B; Chin SF; Rueda OM; Vollan HK; Provenzano E; Bardwell HA; Pugh M; Jones L; Russell R; Sammut SJ; Tsui DW; Liu B; Dawson SJ; Abraham J; Northen H; Peden JF; Mukherjee A; Turashvili G; Green AR; McKinney S; Oloumi A; Shah S; Rosenfeld N; Murphy L; Bentley DR; Ellis IO; Purushotham A; Pinder SE; Børresen-Dale AL; Earl HM; Pharoah PD; Ross MT; Aparicio S; Caldas C
    Nat Commun; 2016 May; 7():11479. PubMed ID: 27161491
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic and predictive value of Ki-67 in triple-negative breast cancer.
    Wang W; Wu J; Zhang P; Fei X; Zong Y; Chen X; Huang O; He JR; Chen W; Li Y; Shen K; Zhu L
    Oncotarget; 2016 May; 7(21):31079-87. PubMed ID: 27145269
    [TBL] [Abstract][Full Text] [Related]  

  • 43. PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma.
    Nghiem PT; Bhatia S; Lipson EJ; Kudchadkar RR; Miller NJ; Annamalai L; Berry S; Chartash EK; Daud A; Fling SP; Friedlander PA; Kluger HM; Kohrt HE; Lundgren L; Margolin K; Mitchell A; Olencki T; Pardoll DM; Reddy SA; Shantha EM; Sharfman WH; Sharon E; Shemanski LR; Shinohara MM; Sunshine JC; Taube JM; Thompson JA; Townson SM; Yearley JH; Topalian SL; Cheever MA
    N Engl J Med; 2016 Jun; 374(26):2542-52. PubMed ID: 27093365
    [TBL] [Abstract][Full Text] [Related]  

  • 44. New insights into the prognostic value of Ki-67 labeling index in patients with triple-negative breast cancer.
    Hao S; He ZX; Yu KD; Yang WT; Shao ZM
    Oncotarget; 2016 Apr; 7(17):24824-31. PubMed ID: 27050075
    [TBL] [Abstract][Full Text] [Related]  

  • 45. COX-2 modulates mammary tumor progression in response to collagen density.
    Esbona K; Inman D; Saha S; Jeffery J; Schedin P; Wilke L; Keely P
    Breast Cancer Res; 2016 Mar; 18(1):35. PubMed ID: 27000374
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multispectral Imaging of T and B Cells in Murine Spleen and Tumor.
    Feng Z; Jensen SM; Messenheimer DJ; Farhad M; Neuberger M; Bifulco CB; Fox BA
    J Immunol; 2016 May; 196(9):3943-50. PubMed ID: 26994219
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Digital image analysis outperforms manual biomarker assessment in breast cancer.
    Stålhammar G; Fuentes Martinez N; Lippert M; Tobin NP; Mølholm I; Kis L; Rosin G; Rantalainen M; Pedersen L; Bergh J; Grunkin M; Hartman J
    Mod Pathol; 2016 Apr; 29(4):318-29. PubMed ID: 26916072
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The tumor microenvironment and Immunoscore are critical determinants of dissemination to distant metastasis.
    Mlecnik B; Bindea G; Kirilovsky A; Angell HK; Obenauf AC; Tosolini M; Church SE; Maby P; Vasaturo A; Angelova M; Fredriksen T; Mauger S; Waldner M; Berger A; Speicher MR; Pagès F; Valge-Archer V; Galon J
    Sci Transl Med; 2016 Feb; 8(327):327ra26. PubMed ID: 26912905
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma.
    Garnelo M; Tan A; Her Z; Yeong J; Lim CJ; Chen J; Lim KH; Weber A; Chow P; Chung A; Ooi LL; Toh HC; Heikenwalder M; Ng IO; Nardin A; Chen Q; Abastado JP; Chew V
    Gut; 2017 Feb; 66(2):342-351. PubMed ID: 26669617
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High Ki67 expression is an independent good prognostic marker in colorectal cancer.
    Melling N; Kowitz CM; Simon R; Bokemeyer C; Terracciano L; Sauter G; Izbicki JR; Marx AH
    J Clin Pathol; 2016 Mar; 69(3):209-14. PubMed ID: 26281861
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis.
    Lovisa S; LeBleu VS; Tampe B; Sugimoto H; Vadnagara K; Carstens JL; Wu CC; Hagos Y; Burckhardt BC; Pentcheva-Hoang T; Nischal H; Allison JP; Zeisberg M; Kalluri R
    Nat Med; 2015 Sep; 21(9):998-1009. PubMed ID: 26236991
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of FGFR1 is an independent prognostic factor in triple-negative breast cancer.
    Cheng CL; Thike AA; Tan SY; Chua PJ; Bay BH; Tan PH
    Breast Cancer Res Treat; 2015 May; 151(1):99-111. PubMed ID: 25868865
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of inflammatory infiltrates in triple negative breast cancer.
    Matsumoto H; Koo SL; Dent R; Tan PH; Iqbal J
    J Clin Pathol; 2015 Jul; 68(7):506-10. PubMed ID: 25750267
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The value of tumor infiltrating lymphocytes (TILs) for predicting response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis.
    Mao Y; Qu Q; Zhang Y; Liu J; Chen X; Shen K
    PLoS One; 2014; 9(12):e115103. PubMed ID: 25501357
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ki67 is a promising molecular target in the diagnosis of cancer (review).
    Li LT; Jiang G; Chen Q; Zheng JN
    Mol Med Rep; 2015 Mar; 11(3):1566-72. PubMed ID: 25384676
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multiplexed immunohistochemistry, imaging, and quantitation: a review, with an assessment of Tyramide signal amplification, multispectral imaging and multiplex analysis.
    Stack EC; Wang C; Roman KA; Hoyt CC
    Methods; 2014 Nov; 70(1):46-58. PubMed ID: 25242720
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199.
    Adams S; Gray RJ; Demaria S; Goldstein L; Perez EA; Shulman LN; Martino S; Wang M; Jones VE; Saphner TJ; Wolff AC; Wood WC; Davidson NE; Sledge GW; Sparano JA; Badve SS
    J Clin Oncol; 2014 Sep; 32(27):2959-66. PubMed ID: 25071121
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic value of Ki67 index in gastrointestinal stromal tumors.
    Zhao WY; Xu J; Wang M; Zhang ZZ; Tu L; Wang CJ; Lin TL; Shen YY; Liu Q; Cao H
    Int J Clin Exp Pathol; 2014; 7(5):2298-304. PubMed ID: 24966939
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neoadjuvant therapy in the treatment of breast cancer.
    Teshome M; Hunt KK
    Surg Oncol Clin N Am; 2014 Jul; 23(3):505-23. PubMed ID: 24882348
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analysis and validation of tissue biomarkers for renal cell carcinoma using automated high-throughput evaluation of protein expression.
    Abel EJ; Bauman TM; Weiker M; Shi F; Downs TM; Jarrard DF; Huang W
    Hum Pathol; 2014 May; 45(5):1092-9. PubMed ID: 24746216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.